Brief: XSpray Announces Positive Stability Data On HyNap-Dasa Tablets
Aug 31 (Reuters) - XSpray Pharma AB (publ) XSPRAY.ST :
* XSPRAY ANNOUNCES POSITIVE STABILITY DATA ON HYNAP-DASA
TABLETS
* SIX MONTHS STABILITY DATA ON COMMERCIALLY MANUFACTURED
HYNAP-DASA DEMONSTRATES THAT TABLETS COMPLIES WITH
SPECIFICATIONS AND THAT THEY CAN BE USED IN AN UPCOMING ANDA
FILING
Source text: https://bit.ly/2EyaKEk
Further company coverage: XSPRAY.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))
Recent news on Xspray Pharma publ AB
See all newsBrief: Xspray Pharma Gets CRL From FDA
Sweden's Xspray Q1 loss narrows, upbeat on Dasynoc prospects
Brief: Xspray Pharma Q1 Pretax Loss SEK 35.4 Mln
Brief: Xspray Pharma To Receive About SEK 113 Million From Rights, Over-Allotment Issues
Brief: FDA Accepts Trade Name Nilopki For Xspray's Drug Candidate XS003